{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:44:07Z","timestamp":1789685047558,"version":"4.0.1"},"reference-count":36,"publisher":"Impact Journals, LLC","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,4,3]]},"DOI":"10.18632\/oncotarget.24644","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T10:21:41Z","timestamp":1522664501000},"page":"17300-17308","source":"Crossref","is-referenced-by-count":20,"title":["MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma"],"prefix":"10.18632","volume":"9","author":[{"given":"Lorenzo","family":"Nicol\u00e8","sequence":"first","affiliation":[{"name":"Department of Medicine, Surgical Pathology & Cytopathology Unit, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Cappellesso","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgical Pathology & Cytopathology Unit, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Sanavia","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Guzzardo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgical Pathology & Cytopathology Unit, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrogio","family":"Fassina","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgical Pathology & Cytopathology Unit, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-publhealth-031811-124704","article-title":"The worldwide pandemic of asbestos-related diseases","volume":"34","author":"Lemen","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Fraire","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-011-1655-3","article-title":"Review on clinical trials of targeted treatments in malignant mesothelioma","volume":"68","author":"S\u00f8rensen","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis","volume":"48","author":"Knuutila","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Powers","year":"2011","journal-title":"Nat Genet"},{"key":"7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Dacic","year":"2016","journal-title":"Mod Pathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","article-title":"Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome","volume":"69","author":"Wiencke","year":"2009","journal-title":"Cancer Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"58606","DOI":"10.18632\/oncotarget.9686","article-title":"Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis","volume":"7","author":"Procopio","year":"2016","journal-title":"Oncotarget"},{"key":"10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3322\/caac.21244","article-title":"MicroRNAome genome: a treasure for cancer diagnosis and therapy","volume":"64","author":"Calin","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"11","doi-asserted-by":"crossref","first-page":"e0170999","DOI":"10.1371\/journal.pone.0170999","article-title":"Identification of MiR-21-5p as a functional regulator of mesothelin expression using MicroRNA capture affinity coupled with next generation sequencing","volume":"12","author":"Greene","year":"2017","journal-title":"PLoS One"},{"key":"12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molonc.2014.11.007","article-title":"MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma","volume":"9","author":"Reid","year":"2015","journal-title":"Mol Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Gaudino","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cncy.21646","article-title":"Young investigator challenge: MicroRNA-21\/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology","volume":"124","author":"Fassina","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"15","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","article-title":"MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer","volume":"27","author":"Allgayer","year":"2008","journal-title":"Oncogene"},{"key":"16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3892\/or_00000838","article-title":"Programmed cell death 4 protein in esophageal cancer","volume":"24","author":"Rugge","year":"2010","journal-title":"Oncol Rep"},{"key":"17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncy.21442","article-title":"Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions","volume":"122","author":"Fassina","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"18","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-13-2429","article-title":"Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition","volume":"20","author":"Petel","year":"2014","journal-title":"Clin Cancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctrv.2014.10.007","article-title":"Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies","volume":"41","author":"Lianes","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/dc.23271","article-title":"Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: complementary statement from the international mesothelioma interest group, also endorsed by the international academy of cytology and the papanicolaou society of cytopathology","volume":"43","author":"Kobayashi","year":"2015","journal-title":"Diagn Cytopathol"},{"key":"21","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cavazza","year":"2015","journal-title":"Mod Pathol"},{"key":"22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Nabeshima","year":"2017","journal-title":"Lung Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cncy.21832","article-title":"Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers","volume":"125","author":"Fassina","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jmoldx.2014.03.002","article-title":"Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma","volume":"16","author":"Santoni-Rugiu","year":"2014","journal-title":"J Mol Diagn"},{"key":"25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40880-016-0158-3","article-title":"The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis","volume":"35","author":"Wong","year":"2016","journal-title":"Chin J Cancer"},{"key":"26","doi-asserted-by":"crossref","first-page":"37227","DOI":"10.1038\/srep37227","article-title":"Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism","volume":"6","author":"Shi","year":"2016","journal-title":"Sci Rep"},{"key":"27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/ddr.21257","article-title":"The role of miR-21 in cancer","volume":"76","author":"Pfeffer","year":"2015","journal-title":"Drug Dev Res"},{"key":"28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00428-011-1046-5","article-title":"PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis","volume":"458","author":"Rugge","year":"2011","journal-title":"Virchows Arch"},{"key":"29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.humpath.2014.09.006","article-title":"The PDCD4\/miR-21 pathway in medullary thyroid carcinoma","volume":"46","author":"Mian","year":"2015","journal-title":"Hum Pathol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1159\/000362946","article-title":"MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma","volume":"33","author":"Song","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"31","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.ejca.2012.12.014","article-title":"Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in mice","volume":"49","author":"Yang","year":"2013","journal-title":"Eur J Cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"e105306","DOI":"10.1371\/journal.pone.0105306","article-title":"Helicobacter pylori promotes epithelial-mesenchymal transition in gastric cancer by downregulating programmed cell death protein 4 (PDCD4)","volume":"9","author":"Jia","year":"2014","journal-title":"PLoS One"},{"key":"33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.toxlet.2014.11.001","article-title":"MicroRNA-21, up-regulated by arsenite, directs the epithelial-mesenchymal transition and enhances the invasive potential of transformed human bronchial epithelial cells by targeting PDCD4","volume":"232","author":"Liu","year":"2015","journal-title":"Toxicol Lett"},{"key":"34","doi-asserted-by":"publisher","first-page":"37269","DOI":"10.18632\/oncotarget.5495","article-title":"MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients","volume":"6","author":"Santarpia","year":"2015","journal-title":"Oncotarget"},{"key":"35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassan","year":"2012","journal-title":"Mod Pathol"},{"key":"36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cncy.21383","article-title":"4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears","volume":"122","author":"Fassan","year":"2014","journal-title":"Cancer Cytopathol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:29:47Z","timestamp":1589038187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":36,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2018,4,3]]}},"alternative-id":["24644","29707109"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24644","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]}}}